Article
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation
10 Aug 2019
Abstract excerpt
The DDX41 gene is a member of the DEAD/H-box RNA helicase family; recurrently mutated in ~1% of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), as well as multiple myeloma and various lymphomas.1, 2 Its exact role in leukemogenesis is not well understood. DDX41 mutations have been involved in the cell mRNA splicing, innate immunity and ribosome biogenesis.2 It can lead to defective RNA splicing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
